Seattle, Washington — According to state and local economic development sources Hematologics plans to invest $1,000,000.00 to build out 13,363 square feet of new space in Seattle. The company plans to occupy the new space at 3161 Elliott Ave in Seattle, on or about July 1, 2023. According to the company website At Hematologics, we diagnose and monitor treatment of leukemia and lymphoma using state of the art technologies. HematoLogics, Inc. is a diagnostic service laboratory established in 1995 and is built on a long history of research. Its principals and staff, who have decades of training and experience, invented many of the techniques that are now standard in the field. HematoLogics, Inc. combines unique expertise in multi-dimensional flow cytometry, tumor cell sorting, cytogenetics, and molecular genetics with a broad understanding of hematopoiesis and clinical knowledge to provide you with the information you need. Our Retrospect DNA Archiving service offers yet one more approach for monitoring your patient for residual disease and determination of relapse.

To learn more about Hematologics, visit http://www.hematologics.com/

Company Contact:
Michael Loken, President
michael@hematologics.com
https://www.linkedin.com/in/michael-loken-a5180/
206-223-2700

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.